Trials / Terminated
TerminatedNCT04278872
Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Sojournix, Inc. · Industry
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy, safety, tolerability, and pharmacokinetics of once daily SJX-653 in postmenopausal women with moderate to severe VMS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SJX-653 | administered orally once daily |
| DRUG | Placebo | administered orally once daily |
Timeline
- Start date
- 2020-11-09
- Primary completion
- 2021-02-12
- Completion
- 2021-04-07
- First posted
- 2020-02-20
- Last updated
- 2022-01-11
- Results posted
- 2022-01-11
Locations
22 sites across 4 countries: Belgium, Germany, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT04278872. Inclusion in this directory is not an endorsement.